University of Wisconsin
Infectious Disease fellowship · Madison, WI · Program website
This program's roster hasn't been collected yet, so there's no list of its own faculty and papers. Below is University of Wisconsin–Madison's research in infectious disease, which the program shares with other departments and affiliated hospitals.
About University of Wisconsin–Madisoninstitution-wide infectious disease research
Infectious Disease publications from University of Wisconsin–Madison and affiliated institutions, since 2022. Updated 2026-11-06; refreshed daily.
148
works per year
15th of 71 infectious disease fellowship programs
-33.7%
2-year growth
48th of 71 infectious disease fellowship programs
29.6%
in top 10% of field (works before 2025)
22nd of 67 infectious disease fellowship programs
61.6%
cited above world average
3rd of 67 infectious disease fellowship programs
Works per year · * 2026 so far
Infectious Diseases · 674
Infectious Disease research topics at University of Wisconsin–Madison
Papers in the window; each links to the list on OpenAlex.
- SARS-CoV-2 and COVID-19 Research 211
- Antifungal resistance and susceptibility 73
- Tuberculosis Research and Epidemiology 70
- COVID-19 Clinical Research Studies 67
- SARS-CoV-2 detection and testing 39
- Clostridium difficile and Clostridium perfringens research 35
- Antimicrobial Resistance in Staphylococcus 34
- HIV/AIDS Research and Interventions 28
Most cited at University of Wisconsin–Madison since 2024
All infectious disease papers there on OpenAlex
- Persistent SARS-CoV-2 infection: significance and implicationsHeather M. Machkovech et al. · The Lancet Infectious Diseases · 2024 · PubMed · cited 155
- Candida auris: Epidemiology and Antifungal StrategyEmily F. Eix et al. · Annual Review of Medicine · 2024 · PubMed · cited 85
- Focus on fungiIliyan Dimitrov Iliev et al. · Cell · 2024 · PubMed · cited 71
- Levofloxacin Preventive Treatment in Children Exposed to MDR TuberculosisAnneke Catharina Hesseling et al. · New England Journal of Medicine · 2024 · PubMed · cited 65
- Nanoparticle-based DNA vaccine protects against SARS-CoV-2 variants in female preclinical modelsLays Cordeiro Guimarães et al. · Nature Communications · 2024 · PubMed · cited 56
- Compensatory evolution in NusG improves fitness of drug-resistant M. tuberculosisKathryn A. Eckartt et al. · Nature · 2024 · PubMed · cited 52
- SARS-CoV-2 variants: biology, pathogenicity, immunity and controlRyuta Uraki et al. · Nature Reviews Microbiology · 2025 · PubMed · cited 47
- Tracing the origin of SARS-CoV-2 omicron-like spike sequences detected in an urban sewershed: a targeted, longitudinal surveillance study of a cryptic wastewater lineageMartin Merrill Shafer et al. · The Lancet Microbe · 2024 · PubMed · cited 42
- Elucidating human gut microbiota interactions that robustly inhibit diverse Clostridioides difficile strains across different nutrient landscapesJordy Evan Sulaiman et al. · Nature Communications · 2024 · PubMed · cited 36
- Marburg Virus Disease in Rwanda, 2024 — Public Health and Clinical ResponsesSabin Nsanzimana et al. · New England Journal of Medicine · 2025 · PubMed · cited 35